Most frequent drug-related events detected by pharmacists during prescription analysis in a University Hospital;Problèmes médicamenteux les plus fréquemment détectés par l'analyse pharmacothérapeutique des prescriptions dans un centre hospitalier universitaire

Revue de Medecine Interne

Volumn 31, Issue 12, 2010, Pages 804-811

  Arques Armoiry, E ^a   Cabelguenne, D ^b   Stamm, C ^b   Janoly Dumenil, A ^a   Grosset Grange, I ^a   Vantard, N ^b   Maire, P ^a   Charpiat, B ^c  

^a HOSPICES CIVILS DE LYON   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c CROIX ROUSSE HOSPITAL   (France)

Author keywords

Adverse drug events; Drug prescriptions; Hospital; Pharmacist; Prevention

Indexed keywords

PARACETAMOL; ZOLPIDEM; ZOPICLONE;

ARTICLE; CONSENSUS; CONTINUING EDUCATION; DIGESTIVE SYSTEM; DRUG ABSORPTION; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; DRUG OVERDOSE; EDUCATION PROGRAM; HEALTH CARE PERSONNEL; MEDICATION ERROR; PHARMACEUTICAL CARE; PHARMACIST; POLICY; PRESCRIPTION; TABLET FORMULATION; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

EID: 78649495966     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.08.001     Document Type: Article

References (43)

1. Arrêté du 9 août 1991 portant application de l'article R5203 du Code de la santé publique dans les établissements mentionnés à l'article L577. JO du 11 octobre 1991.
2. Dooley M.J., Allen K.M., Doecke C.J., Galbraith K.J., Taylor G.R., Bright J., et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 2004, 57:513-521.
3. Schmitt E. Le risque médicamenteux nosocomial. Circuit hospitalier du médicament et qualité des soins 1999, Masson, Paris.
4. Hawkey C.J., Hodgson S., Norman A., Daneshmend T.K., Garner S.T. Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ 1990, 300:986-990.
5. Leape L.L., Cullen D.J., Clapp M.D., Burdick E., Demonaco H.J., Erickson J.I., et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999, 282:267-270.
6. Vernardet S., Bossaert S., Livrozet A., Pont E., Charpiat B. Bilan de cinq années d'analyses et de validations pharmaceutiques des prescriptions. Presse Med 2005, 34:990-996.
7. Bedouch P., Charpiat B., Conort O., Rose F.X., Escofier L., Juste M., et al. Assessment of clinical pharmacists' interventions in French hospitals: results of a multicenter study. Ann Pharmacother 2008, 42:1095-1103.
8. Bedouch P., Allenet B., Grass A., Labarère J., Brudieu E., Bosson J.L., et al. Drug-related problems in medical wards with a computerized physician order entry system. J Clin Pharm Ther 2009, 34:187-195.
9. Estellat C., Colombet I., Vautier S., Huault-Quentel J., Durieux P., Sabatier B. Impact of pharmacy validation in a computerized physician order entry context. Int J Qual Health Care 2007, 19:317-325.
10. Dumortier G., Van Nieuwenhuyse V., Zerrouk A., Chebili S., Glikman J., Degrassat K Démarche qualité dans le circuit du médicament grâce à l'analyse pharmaceutique des ordonnances dans un établissement de soins psychiatriques. Encephale 1999, 25:323-328.
11. Cabelguenne D., Sourty A., Meunier F., Beaupere P., Bert A., Pittel-Buttez M.A. Comment concilier pharmacie clinique et évaluation des pratiques professionnelles: exemple de la démarche des équipes médicales et pharmaceutiques des prisons de Lyon. J Pharm Clin 2007, 26:158-165.
12. Allenet B., Bedouch P., Rose F.X., Escofier L., Roubille R., Charpiat B., et al. Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharm World Sci 2006, 28:181-188.
13. Bedouch P., Charpiat B., Roubille R., Juste M., Rose F.X., Escofier L., et al. Documentation des interventions pharmaceutiques sur le site Internet de la Société française de pharmacie clinique: finalité, mode d'emploi et perspectives. J Pharm Clin 2007, 26:40-44.
14. Holland R., Desborough J., Goodyer L., Hall S., Wright D., Loke Y.K. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008, 65:303-316.
15. Krähenbühl J.M., Kremer B., Guignard B., Bugnon O. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci 2008, 30:777-786.
16. Risque d'hépatotoxicité inhérent au paracétamol et en particulier aux solutions pour perfusion Perfalgan® (paracétamol) 07/07/2008. Information destinée aux pharmaciens hospitaliers et COMEDIMS. Consultable sur: (accès le 29/10/2009). http://www.afssaps.fr/Infos-de-securite/Lettres-aux-professionnels-de-sante/Risque-d-hepatotoxicite-inherent-au-paracetamol-et-en-particulier-aux-solutions-pour-perfusion-PERFALGAN-R-paracetamol.
17. Modalités d'arrêt des benzodiazépines et médicaments apparentés chez le patient âgé - synthèse des recommandations, Recommandations, argumentaire - recommandations pour la pratique clinique - HAS - octobre 2007, mises en ligne en novembre. Consultable sur: http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_bzd_-_version_finale_2008.pdf.
18. Glass J., Lanctôt K.L., Herrmann N., Sproule B.A., Busto U.E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005, 331:1169.
19. Rhalimi M., Helou R., Jaecker P. Medication use and increased risk of falls in hospitalized elderly patients: a retrospective, case-control study. Drugs Aging 2009, 26:847-852.
20. Champion K., Delcey V., Bergmann JF Attention: perfusion !. Rev Med Interne 2007, 28:729-730.
21. Ripouteau C., Conort O., Lamas J.P., Auleley G.R., Hazebroucq G., Durieux P. Effect of multifaceted intervention promoting early switch from intravenous to oral acetaminophen for postoperative pain: controlled, prospective, before and after study. BMJ 2000, 321:1460-1463.
22. Schier J.G., Howland M.A., Hoffman R.S., Nelson L.S. Fatality from administration of labetalol and crushed extended-release nifedipine. Ann Pharmacother 2003, 37:1420-1423.
23. Ech-Chaouya A., Giesenfelda A., Zieglerb O., Quilliot D. Médicaments et nutrition entérale: audit sur la galénique, le pilage et le mode d'administration. Nutr Clin Metab 2007, 21:115-119.
24. Philipneri M.D., Rocca Rey L.A., Schnitzler M.A., Abbott K.C., Brennan D.C., Takemoto S.K., et al. Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol 2008, 12:41-52.
25. Agence française de sécurité sanitaire des produits de santé. Thesaurus: référentiel national des interactions médicamenteuses, (juin 2009). Consultable sur: (accès le 06/12/2009). http://afssaps.sante.fr/htm/10/iam/indiam.htm.
26. Suda K.J., Garey K.W., Danziger L.H. Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone. Pharm World Sci 2005, 27:81-82.
27. Quain R.D., Barton T.D., Fishman N.O., Weiner M.G., Lautenbach E. Coadministration of oral levofloxacin with agents that impair its absorption: potential impact on emergence of resistance. Int J Antimicrob Agents 2005, 26:327-330.
28. Ammenwerth E., Talmon J., Ash J.S., Bates D.W., Beuscart-Zéphir M.C., Duhamel A., et al. Impact of CPOE on mortality rates - contradictory findings, important messages. Methods Inf Med 2006, 45:586-593.
29. van Rosse F., Maat B., Rademaker C.M., van Vught A.J., Egberts A.C., Bollen C.W. The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review. Pediatrics 2009, 123:1184-1190.
30. Koppel R., Metlay J.P., Cohen A., Abaluck B., Localio A.R., Kimmel S.E., et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA 2005, 293:1197-1203.
31. Reynolds K., Peres A., Tatham J.M. The impact on patient safety of free-text entry of nursing orders into an electronic medical record in an integrated delivery system. AMIA Annu Symp Proc 2005, 1095.
32. Chused A.E., Kuperman G.J., Stetson P.D. Alert override reasons: a failure to communicate. AMIA Annu Symp Proc 2008, 111-115.
33. Singh H., Mani S., Espadas D., Petersen N., Franklin V., Petersen L.A. Prescription errors and outcomes related to inconsistent information transmitted through computerized order entry: a prospective study. Arch Intern Med 2009, 169:982-989.
34. Cousins D.D., Kagemann L. Medication errors: National findings from the USP MEDMARK medication error reporting program. Hospital Pharmacy 2006, 41(Suppl. 1):S3-S10.
35. Kucukarslan S.N., Peters M., Mlynarek M., Nafziger D.A. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003, 163:2014-2018.
36. Barber N.D., Batty R., Ridout D.A. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 1997, 54:397-405.
37. Kaboli P.J., Hoth A.B., McClimon B.J., Schnipper J.L. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med 2006, 166:955-964.
38. De Bruin M.L., Langendijk P.N., Koopmans R.P., Wilde A.A., Leufkens H.G., Hoes A.W. In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 2007, 63:216-223.
39. Van der Sijs H., Kowlesar R., Klootwijk A.P., Nelwan S.P., Vulto A.G., van Gelder T. Clinically relevant QTc-prolongation due to overridden drug-drug interaction alerts: a retrospective cohort study. Br J Clin Pharmacol 2009, 67:347-354.
40. Van der Sijs H., Kowlesar R., Aarts J., Berg M., Vulto A., van Gelder T. Unintended consequences of reducing QT-alert overload in a computerized physician order entry system. Eur J Clin Pharmacol 2009, 65:919-925.
41. Semple S.J., Roughead E.E. Medication safety in acute care in Australia: where are we now? Part 2: a review of strategies and activities for improving medication safety 2002-2008. Aust New Zealand Health Policy 2009, 6:24.
42. Li Wan Po A. Drug-drug interactions and adverse drug reactions: the bollards and flashing lights syndrome. J Clin Pharm Ther 2005, 30:97-99.
43. Jenders R.A., Osheroff J.A., Sittig D.F., Pifer E.A., Teich J.M. Recommendations for clinical decision support deployment: synthesis of a roundtable of medical directors of information systems. AMIA Annu Symp Proc 2007, 359-363.